DOJ Announces Manufacturing Regs as 'Top Area of Focus'

The U.S. Department of Justice (DOJ) has announced that current good manufacturing practices (CGMPs) will be one of the agency's "top areas of focus" in the coming year, opening up new areas of uncertainty for those involved in compliance and regulatory activities for the pharmaceutical industry.